U.S. drive to onshore battery supply chains could create big winners in lithium
Investor Find Lithium Gold and Crush the Bear Market with 32k Metric Tons
Download Free Report
Joseph C.  Sardano net worth and biography

Joseph Sardano Biography and Net Worth

Joseph C. Sardano serves as Chairman of the Board, President, Chief Executive Officer, Co-Founder of the Company. Mr. Sardano is our co-founder and has served as our President, Chief Executive Officer and Chairman of the Board since our inception in 2010. From 2008 to 2009, Mr. Sardano served as Chief Commercial Officer of Xoft, Inc., an electronic brachytherapy medical device company. From 2005 to 2008, Mr. Sardano served as managing partner and healthcare consultant for Molecular Imaging Ventures. From 2002 to 2005, Mr. Sardano served as Sr. Vice President of Global Sales and Marketing of CTI Molecular Imaging and Pet Net Pharmaceuticals, a developer of imaging and isotope solutions for the healthcare industry acquired by Siemens Medical Solutions, of which Mr. Sardano served as Vice President in 2005. From 1998 to 2002, Mr. Sardano served as Americas Sales Manager for Functional Imaging at GE Medical Systems. From 1997 to 1998, Mr. Sardano served as Vice President of Sales and Marketing for Elscint Inc., a developer and manufacturer of medical imaging solutions, including nuclear medicine, computed tomography magnetic resonance imaging and x-ray scanners, the imaging activities of which were sold to GE Medical Systems in 1999. From 1991 to 1995, Mr. Sardano served as Region Sales Manager of Toshiba America Medical Systems. Mr. Sardano has a Bachelor of Arts degree from Concordia University in Montreal, Canada, as well as several Business Certificates from McGill University School of Management. Our Board believes that Mr. Sardano’s breadth of experience with and leadership of the introduction and commercialization of new technologies and services within the healthcare industry qualifies him to serve as our President, Chief Executive Officer and Chairman of the Board.

What is Joseph C. Sardano's net worth?

The estimated net worth of Joseph C. Sardano is at least $3.10 million as of September 14th, 2023. Mr. Sardano owns 1,175,293 shares of Sensus Healthcare stock worth more than $3,102,774 as of September 28th. This net worth approximation does not reflect any other investments that Mr. Sardano may own. Additionally, Mr. Sardano receives a salary of $754,430.00 as CEO at Sensus Healthcare. Learn More about Joseph C. Sardano's net worth.

How old is Joseph C. Sardano?

Mr. Sardano is currently 70 years old. There are 4 older executives and no younger executives at Sensus Healthcare. Learn More on Joseph C. Sardano's age.

What is Joseph C. Sardano's salary?

As the CEO of Sensus Healthcare, Inc., Mr. Sardano earns $754,430.00 per year. Learn More on Joseph C. Sardano's salary.

How do I contact Joseph C. Sardano?

The corporate mailing address for Mr. Sardano and other Sensus Healthcare executives is 851 BROKEN SOUND PARKWAY NW SUITE 215, BOCA RATON FL, 33487. Sensus Healthcare can also be reached via phone at (561) 922-5808 and via email at [email protected]. Learn More on Joseph C. Sardano's contact information.

Has Joseph C. Sardano been buying or selling shares of Sensus Healthcare?

In the last ninety days, Joseph C. Sardano has bought $67,400.00 in shares of Sensus Healthcare stock. Most recently, on Thursday, September 14th, Joseph C. Sardano bought 10,000 shares of Sensus Healthcare stock. The stock was acquired at an average cost of $2.88 per share, with a total value of $28,800.00. Following the completion of the transaction, the chief executive officer now directly owns 1,175,293 shares of the company's stock, valued at $3,384,843.84. Learn More on Joseph C. Sardano's trading history.

Who are Sensus Healthcare's active insiders?

Sensus Healthcare's insider roster includes Stephen Cohen (EVP), and Joseph Sardano (CEO). Learn More on Sensus Healthcare's active insiders.

Are insiders buying or selling shares of Sensus Healthcare?

In the last twelve months, Sensus Healthcare insiders bought shares 8 times. They purchased a total of 52,511 shares worth more than $164,010.45. The most recent insider tranaction occured on September, 14th when CEO Joseph C Sardano bought 10,000 shares worth more than $28,800.00. Insiders at Sensus Healthcare own 11.1% of the company. Learn More about insider trades at Sensus Healthcare.

Information on this page was last updated on 9/14/2023.

Joseph C. Sardano Insider Trading History at Sensus Healthcare

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/14/2023Buy10,000$2.88$28,800.001,175,293View SEC Filing Icon  
8/8/2023Buy10,000$3.86$38,600.001,165,293View SEC Filing Icon  
5/9/2023Buy17,075$2.99$51,054.251,147,368View SEC Filing Icon  
8/11/2022Sell28,999$14.21$412,075.791,171,881View SEC Filing Icon  
8/9/2022Sell36,093$13.97$504,219.211,294,200View SEC Filing Icon  
3/11/2022Sell44,782$10.11$452,746.02View SEC Filing Icon  
3/9/2022Sell50,274$10.19$512,292.06View SEC Filing Icon  
12/16/2021Sell10,926$7.02$76,700.52View SEC Filing Icon  
12/14/2021Sell13,969$7.22$100,856.18View SEC Filing Icon  
12/9/2021Sell21,930$7.79$170,834.70View SEC Filing Icon  
9/10/2018Sell1,857$7.55$14,020.351,539,701View SEC Filing Icon  
8/28/2018Sell1,166$7.50$8,745.001,541,880View SEC Filing Icon  
8/9/2018Sell6,170$7.50$46,275.00View SEC Filing Icon  
8/2/2018Sell350$7.50$2,625.001,549,216View SEC Filing Icon  
6/25/2018Sell10,854$7.52$81,622.081,561,174View SEC Filing Icon  
6/20/2018Sell7,945$7.52$59,746.401,578,349View SEC Filing Icon  
6/18/2018Sell9,352$7.52$70,327.041,578,349View SEC Filing Icon  
10/27/2017Sell6,953$6.00$41,718.001,587,701View SEC Filing Icon  
9/12/2017Sell12,192$6.00$73,152.001,605,751View SEC Filing Icon  
9/6/2017Sell13,320$6.00$79,920.001,614,099View SEC Filing Icon  
9/5/2017Sell9,579$6.00$57,474.001,614,099View SEC Filing Icon  
8/28/2017Sell9,625$6.00$57,750.001,625,821View SEC Filing Icon  
8/24/2017Sell8,167$6.00$49,002.001,637,891View SEC Filing Icon  
12/2/2016Sell274$6.00$1,644.001,641,636View SEC Filing Icon  
11/30/2016Sell924$6.00$5,544.001,642,264View SEC Filing Icon  
See Full Table

Joseph C. Sardano Buying and Selling Activity at Sensus Healthcare

This chart shows Joseph C Sardano's buying and selling at Sensus Healthcare by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Sensus Healthcare Company Overview

Sensus Healthcare logo
Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and TransDermal Infusion system. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body, as well as distributes laser devices. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.
Read More

Today's Range

Now: $2.65
Low: $2.63
High: $2.68

50 Day Range

MA: $3.02
Low: $2.62
High: $3.91

2 Week Range

Now: $2.65
Low: $2.29
High: $14.75


37,811 shs

Average Volume

184,850 shs

Market Capitalization

$43.44 million

P/E Ratio


Dividend Yield



Unlock the treasure on Mount Olympus with this little-known mining stock.
Investor Find Lithium Gold and Crush the Bear Market with 32k Metric Tons
Download Free Report